Pars Vaccine Technology Company was established in 2011 in order to achieve and localize new technologies in the country's vaccine industry, especially viral vaccines. Since then, the central core of the company, by creating various research groups appropriate to the subject, first identified the technological gaps between the existing vaccine knowledge in the country with the progress made in the global arena, and then by implementing the process of research and development of technical knowledge. Novin has been localized for use in the domestic vaccine industry.